Microbix Biosystems (TSX:MBX) reported quarterly losses of $(0.01) per share which beat the analyst consensus estimate of $(0.68) by 98.53 percent. This is a 0 percent increase over losses of $(0.01) per share from the same period last year. The company reported quarterly sales of $4.059 million which missed the analyst consensus estimate of $5.200 million by 21.94 percent. This is a 16.91 percent increase over sales of $3.472 million the same period last year.